Abstract:In the absence of markedly better efficacy against the various indications for tetracyclines, the minocycline benefit/risk ratio was clearly lower than that of doxycycline, and possibly those of lymecycline and metacycline. In light of these findings, minocycline should no longer be considered first-line therapy for inflammatory skin disorders, especially acne.
“…Although tetracycline-induced cardiac adverse reactions have been described ( 10 ) and the patient reported here had signs of myopericarditis shortly after the initiation of doxycycline, he completed a 4-week treatment without recurrence. Therefore, the clinical picture seems unlikely to be attributable to doxycycline-induced toxicity.…”
“…Although tetracycline-induced cardiac adverse reactions have been described ( 10 ) and the patient reported here had signs of myopericarditis shortly after the initiation of doxycycline, he completed a 4-week treatment without recurrence. Therefore, the clinical picture seems unlikely to be attributable to doxycycline-induced toxicity.…”
“…Serious adverse reactions, including autoimmune disorders and hypersensitivity reactions, such as drug reaction with eosinophilia and systemic symptoms, have been described more often with the use of minocycline than with the other tetracylines . Although the frequency is very low, unlike the other tetracyclines, including doxycycline, minocycline is associated with lupus erythematosus .…”
Section: Discussionmentioning
confidence: 99%
“…Although the frequency is very low, unlike the other tetracyclines, including doxycycline, minocycline is associated with lupus erythematosus . This risk must be weighed against the benefit of minocycline and, consequently, minocycline must not be considered the first‐line treatment against inflammatory diseases …”
Minocycline 100 mg is noninferior to doxycycline 40 mg in efficacy over a 16- week treatment period. At follow-up, RosaQoL and PaGA were statistically significantly more improved in the minocycline group than in the doxycycline group, and minocycline 100 mg gives longer remission. In this study there was no significant difference in safety between these treatments; however, based on previous literature minocycline has a lower risk-to-benefit ratio than doxycycline. Minocycline 100 mg may be a good alternative treatment for those patients who, for any reason, are unable or unwilling to take doxycycline 40 mg.
“…, Lebrun‐Vignes et al . , Travassos et al . ), only one recent letter to the Editor of a dental journal has reported an allergy to Ledermix paste due to demeclocycline, one of the Ledermix paste components that belongs to the tetracycline family (Jetty & Sidebottom ).…”
A 33-year-old female patient undergoing root canal retreatment of her right mandibular second premolar tooth experienced symptoms of type 1 allergy following the placement of an intracanal medicament containing a mixture of Ledermix paste and calcium hydroxide [Ca(OH)2 ]. Signs of the type 1 allergy included urticaria, pruritus all over the body, general malaise and fever. These all subsided after removing and flushing out the Ledermix paste-Ca(OH)2 mixture and redressing the root canal with Ca(OH)2 alone. Allergic scratch tests were performed, and these confirmed that the patient was allergic to tetracycline, one of the components of Ledermix paste.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.